Hemodialysis for Lactic Acidosis
- PMID: 28904487
- PMCID: PMC5588492
- DOI: 10.4103/ijccm.IJCCM_167_17
Hemodialysis for Lactic Acidosis
Abstract
Lactic acidosis (Type A) is common in critically ill patients and usually treated by correcting the underlying etiology. We present the case of a young female who presented with life-threatening lactic acidosis secondary to hematological malignancy. Timely initiation of hemodialysis was lifesaving. The case highlights the importance of considering Type B lactic acidosis (in this case secondary to a hematological malignancy) and also initiating renal replacement therapy when routine measures are ineffective.
Keywords: Hematological malignancy; hemodialysis; hyperlactatemia; lactic acidosis; malignancy.
Conflict of interest statement
There are no conflicts of interest.
References
-
- Warburg O, Posener K, Negelein E. Über den stoffwechsel der carcinomzelle. Biochem Z. 1924;152:309–44.
-
- Mazurek S, Boschek CB, Eigenbrodt E. The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy. J Bioenerg Biomembr. 1997;29:315–30. - PubMed
-
- Werner H, LeRoith D. The role of the insulin-like growth factor system in human cancer. Adv Cancer Res. 1996;68:183–223. - PubMed
-
- Glasheen JJ, Sorensen MD. Burkitt's lymphoma presenting with lactic acidosis and hypoglycemia – A case presentation. Leuk Lymphoma. 2005;46:281–3. - PubMed
-
- Sillos EM, Shenep JL, Burghen GA, Pui CH, Behm FG, Sandlund JT. Lactic acidosis: A metabolic complication of hematologic malignancies: Case report and review of the literature. Cancer. 2001;92:2237–46. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources